These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 22167651)
1. Mesenchymal stem cell therapy on murine model of nonalcoholic steatohepatitis. Sakai Y; Kaneko S Methods Mol Biol; 2012; 826():217-23. PubMed ID: 22167651 [TBL] [Abstract][Full Text] [Related]
2. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. di Bonzo LV; Ferrero I; Cravanzola C; Mareschi K; Rustichell D; Novo E; Sanavio F; Cannito S; Zamara E; Bertero M; Davit A; Francica S; Novelli F; Colombatto S; Fagioli F; Parola M Gut; 2008 Feb; 57(2):223-31. PubMed ID: 17639088 [TBL] [Abstract][Full Text] [Related]
3. Nonexpanded mesenchymal stem cells for regenerative medicine: yield in stromal vascular fraction from adipose tissues. Faustini M; Bucco M; Chlapanidas T; Lucconi G; Marazzi M; Tosca MC; Gaetani P; Klinger M; Villani S; Ferretti VV; Vigo D; Torre ML Tissue Eng Part C Methods; 2010 Dec; 16(6):1515-21. PubMed ID: 20486782 [TBL] [Abstract][Full Text] [Related]
4. Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model. Winkler S; Borkham-Kamphorst E; Stock P; Brückner S; Dollinger M; Weiskirchen R; Christ B Exp Cell Res; 2014 Aug; 326(2):230-9. PubMed ID: 24786317 [TBL] [Abstract][Full Text] [Related]
5. Adipose tissue-derived stem cells as a regenerative therapy for a mouse steatohepatitis-induced cirrhosis model. Seki A; Sakai Y; Komura T; Nasti A; Yoshida K; Higashimoto M; Honda M; Usui S; Takamura M; Takamura T; Ochiya T; Furuichi K; Wada T; Kaneko S Hepatology; 2013 Sep; 58(3):1133-42. PubMed ID: 23686813 [TBL] [Abstract][Full Text] [Related]
6. Commitment of stem cells into functional hepatocytes. Ochiya T; Yamamoto Y; Banas A Differentiation; 2010 Feb; 79(2):65-73. PubMed ID: 19883970 [TBL] [Abstract][Full Text] [Related]
7. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kato T; Okochi H; Ochiya T J Gastroenterol Hepatol; 2009 Jan; 24(1):70-7. PubMed ID: 18624899 [TBL] [Abstract][Full Text] [Related]
9. No contribution of multipotent mesenchymal stromal cells to liver regeneration in a rat model of prolonged hepatic injury. Popp FC; Slowik P; Eggenhofer E; Renner P; Lang SA; Stoeltzing O; Geissler EK; Piso P; Schlitt HJ; Dahlke MH Stem Cells; 2007 Mar; 25(3):639-45. PubMed ID: 17110617 [TBL] [Abstract][Full Text] [Related]
10. Analysis of biodistribution and engraftment into the liver of genetically modified mesenchymal stromal cells derived from adipose tissue. Di Rocco G; Gentile A; Antonini A; Truffa S; Piaggio G; Capogrossi MC; Toietta G Cell Transplant; 2012; 21(9):1997-2008. PubMed ID: 22469297 [TBL] [Abstract][Full Text] [Related]
11. Hepatic transplantation of mesenchymal stem cells in rodent animal models. Christ B; Brückner S; Stock P Methods Mol Biol; 2011; 698():315-30. PubMed ID: 21431529 [TBL] [Abstract][Full Text] [Related]
12. Effect of partial hepatectomy on in vivo engraftment after intravenous administration of human adipose tissue stromal cells in mouse. Kim DH; Je CM; Sin JY; Jung JS Microsurgery; 2003; 23(5):424-31. PubMed ID: 14557995 [TBL] [Abstract][Full Text] [Related]
13. Adipose-derived mesenchymal stem cells and regenerative medicine. Konno M; Hamabe A; Hasegawa S; Ogawa H; Fukusumi T; Nishikawa S; Ohta K; Kano Y; Ozaki M; Noguchi Y; Sakai D; Kudoh T; Kawamoto K; Eguchi H; Satoh T; Tanemura M; Nagano H; Doki Y; Mori M; Ishii H Dev Growth Differ; 2013 Apr; 55(3):309-18. PubMed ID: 23452121 [TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells for tissue engineering and regenerative medicine. Tae SK; Lee SH; Park JS; Im GI Biomed Mater; 2006 Jun; 1(2):63-71. PubMed ID: 18460758 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Aurich H; Sgodda M; Kaltwasser P; Vetter M; Weise A; Liehr T; Brulport M; Hengstler JG; Dollinger MM; Fleig WE; Christ B Gut; 2009 Apr; 58(4):570-81. PubMed ID: 19022918 [TBL] [Abstract][Full Text] [Related]
16. Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells--potential and pitfalls. Aicher WK; Bühring HJ; Hart M; Rolauffs B; Badke A; Klein G Adv Drug Deliv Rev; 2011 Apr; 63(4-5):342-51. PubMed ID: 21184789 [TBL] [Abstract][Full Text] [Related]
17. Clinical study using adipose-derived mesenchymal-like stem cells in acute myocardial infarction and heart failure. Panfilov IA; de Jong R; Takashima S; Duckers HJ Methods Mol Biol; 2013; 1036():207-12. PubMed ID: 23807797 [TBL] [Abstract][Full Text] [Related]
19. Multipotent cells from the human third molar: feasibility of cell-based therapy for liver disease. Ikeda E; Yagi K; Kojima M; Yagyuu T; Ohshima A; Sobajima S; Tadokoro M; Katsube Y; Isoda K; Kondoh M; Kawase M; Go MJ; Adachi H; Yokota Y; Kirita T; Ohgushi H Differentiation; 2008 May; 76(5):495-505. PubMed ID: 18093227 [TBL] [Abstract][Full Text] [Related]
20. [Advances of stem cell-based liver regeneration: science and the future]. Ochiya T Nihon Rinsho; 2011 Dec; 69(12):2156-60. PubMed ID: 22242313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]